基于双参数MRI的人工智能算法的外部验证及其与常规PI-RADS模拟整合用于前列腺癌检测
本回顾性队列研究在144例接受前列腺MRI及靶向和系统穿刺活检的患者中外部验证了基于双参数MRI的AI模型,AI检测前列腺癌的敏感度(86.6%)和临床显著前列腺癌的敏感度(88.4%)与放射科医生(分别为85.7%和89.5%)相当;模拟整合AI与PI-RADS使临床显著前列腺癌敏感度提高5.8%(p=0.025),AI联合PI-RADS及PSA密度诊断临床显著前列腺癌的AUC为0.76。
要点
- AI检测前列腺癌敏感度86.6%、临床显著前列腺癌敏感度88.4%,与放射科医生(85.7%、89.5%)无显著差异。
- 模拟整合AI与PI-RADS使临床显著前列腺癌敏感度提高5.8%(p=0.025)。
- AI联合PI-RADS及PSA密度诊断临床显著前列腺癌的AUC为0.76,为最佳诊断性能组合。
核心结论
- AI算法检测前列腺癌的检出率与PI-RADS相当,AI与放射科医生判读联合可提高敏感度,可能有助于评估低风险和不确定的PI-RADS病变;AI在前列腺癌筛查中的作用尚需进一步阐明。
研究设计与样本
- 回顾性队列研究,连续纳入2022年1月至2024年3月期间在一家泌尿科诊所接受前列腺MRI并随后行靶向和系统前列腺活检的144例患者,外部验证基于双参数MRI的AI模型,放射科医生判读遵循PI-RADS v2.1,活检依据PI-RADS评分进行,AI模型提供病灶分割和癌症概率图并与活检结果比较。
诊断标准与关键数值
- AI检测前列腺癌敏感度86.6%,检测临床显著前列腺癌敏感度88.4%;放射科医生检测前列腺癌敏感度85.7%(与AI比较p=0.84),检测临床显著前列腺癌敏感度89.5%(与AI比较p=0.80);模拟整合AI与PI-RADS使临床显著前列腺癌敏感度提高5.8%(p=0.025);AI联合PI-RADS及PSA密度诊断临床显著前列腺癌的AUC=0.76。
临床应用与阅片要点
- 对索引PI-RADS 3类研究进行模拟,将AI预测升级为PI-RADS 4类以调整活检阈值;AI联合放射科医生判读可提高临床显著前列腺癌敏感度,可能有助于评估低风险和不确定的PI-RADS病变;AI在前列腺癌筛查中的作用尚需进一步阐明。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Prostate imaging reporting and data systems (PI-RADS) experiences considerable variability in inter-reader performance. Artificial Intelligence (AI) algorithms were suggested to provide comparable performance to PI-RADS for assessing prostate cancer (PCa) risk, albeit tested in highly selected cohorts. This study aimed to assess an AI algorithm for PCa detection in a clinical practice setting and simulate integration of the AI model with PI-RADS for assessment of indeterminate PI-RADS 3 lesions.
PATIENTS AND METHODS: This retrospective cohort study externally validated a biparametric MRI-based AI model for PCa detection in a consecutive cohort of patients who underwent prostate MRI and subsequently targeted and systematic prostate biopsy at a urology clinic between January 2022 and March 2024. Radiologist interpretations followed PI-RADS v2.1, and biopsies were conducted per PI-RADS scores. The previously developed AI model provided lesion segmentations and cancer probability maps which were compared to biopsy results. Additionally, we conducted a simulation to adjust biopsy thresholds for index PI-RADS category 3 studies, where AI predictions within these studies upgraded them to PI-RADS category 4.
RESULTS: Among 144 patients with a median age of 70 years and PSA density of 0.17ng/mL/cc, AI's sensitivity for detection of PCa (86.6%) and clinically significant PCa (csPCa, 88.4%) was comparable to radiologists (85.7%, p=0.84, and 89.5%, p=0.80, respectively). The simulation combining radiologist and AI evaluations improved clinically significant PCa sensitivity by 5.8% (p=0.025). The combination of AI, PI-RADS and PSA density provided the best diagnostic performance for csPCa (area under the curve [AUC]=0.76).
CONCLUSION: The AI algorithm demonstrated comparable PCa detection rates to PI-RADS. The combination of AI with radiologist interpretation improved sensitivity and could be instrumental in assessment of low-risk and indeterminate PI-RADS lesions. The role of AI in PCa screening remains to be further elucidated.
引用
- Belue MJ, Mukhtar V, Ram R, et al. External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection. Acad Radiol. 2025. PMID: 40221284. doi:10.1016/j.acra.2025.03.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。